- Home
- DFLI vs NXTC Comparison
DFLI vs NXTC Comparison
Compare DFLI & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFLI
- NXTC
- Stock Information
- Founded
- DFLI 2020
- NXTC 2015
- Country
- DFLI United States
- NXTC United States
- Employees
- DFLI N/A
- NXTC N/A
- Industry
- DFLI Electronic Components
- NXTC Biotechnology: Pharmaceutical Preparations
- Sector
- DFLI Technology
- NXTC Health Care
- Exchange
- DFLI Nasdaq
- NXTC Nasdaq
- Market Cap
- DFLI 14.5M
- NXTC 12.8M
- IPO Year
- DFLI N/A
- NXTC 2019
- Fundamental
- Price
- DFLI $0.29
- NXTC $4.89
- Analyst Decision
- DFLI Strong Buy
- NXTC Strong Buy
- Analyst Count
- DFLI 1
- NXTC 2
- Target Price
- DFLI $1.50
- NXTC $25.50
- AVG Volume (30 Days)
- DFLI 24.4M
- NXTC 20.4K
- Earning Date
- DFLI 08-14-2025
- NXTC 08-07-2025
- Dividend Yield
- DFLI N/A
- NXTC N/A
- EPS Growth
- DFLI N/A
- NXTC N/A
- EPS
- DFLI N/A
- NXTC N/A
- Revenue
- DFLI $54,536,000.00
- NXTC N/A
- Revenue This Year
- DFLI $28.01
- NXTC N/A
- Revenue Next Year
- DFLI $43.54
- NXTC N/A
- P/E Ratio
- DFLI N/A
- NXTC N/A
- Revenue Growth
- DFLI 4.80
- NXTC N/A
- 52 Week Low
- DFLI $0.15
- NXTC $2.69
- 52 Week High
- DFLI $5.78
- NXTC $19.20
- Technical
- Relative Strength Index (RSI)
- DFLI 50.45
- NXTC 43.45
- Support Level
- DFLI $0.28
- NXTC $4.94
- Resistance Level
- DFLI $0.37
- NXTC $5.28
- Average True Range (ATR)
- DFLI 0.04
- NXTC 0.25
- MACD
- DFLI -0.00
- NXTC -0.00
- Stochastic Oscillator
- DFLI 27.32
- NXTC 15.85
About DFLI Dragonfly Energy Holdings Corp. (NV)
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.